Literature DB >> 12671900

A multidrug resistance 3 gene mutation causing cholelithiasis, cholestasis of pregnancy, and adulthood biliary cirrhosis.

Juan-Felipe Lucena1, J Ignacio Herrero, Jorge Quiroga, Bruno Sangro, Jesus Garcia-Foncillas, Natalia Zabalegui, Josu Sola, Maite Herraiz, Juan F Medina, Jesus Prieto.   

Abstract

We describe a 47-year-old patient who developed cholelithiasis in adolescence, followed by recurrent intrahepatic cholestasis of pregnancy, and finally biliary cirrhosis in adulthood. In our patient, the consecutive presentation of the 3 mentioned disorders raised the suspicion of a defect of MDR3, the canalicular protein involved in the transport of phospatidylcholine to bile. Mutational analysis in our patient showed a heterozygous missense mutation of the MDR3 gene that has not been described previously, which occurs in exon 14 at codon 535, and results in the substitution of glycine for aspartic acid. Further analysis of 7 members of the family showed the same mutation in her daughter who, on follow-up, developed cholestasis of pregnancy and persisting high serum levels of gamma-glutamyl transpeptidase and alkaline phosphatase after delivery. Although biliary cirrhosis associated with MDR3 deficiency typically appears before the age of 25 years, in our case, the relatively mild MDR3 dysfunction allowed for a slower progression of the disease with established, well-advanced cirrhosis in the fifth decade of life. The present case, which accumulates the 3 clinical disorders assocaited with MDR3 deficiency, shows that this condition should be suspected not only in children or young people with high gamma-glutamyl transpeptidase cholestasis but also in middle-aged or older patients with chronic idiopathic cholestasis, especially when there is a previous history of cholestasis of pregnancy or juvenile cholelithiasis.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12671900     DOI: 10.1053/gast.2003.50144

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  39 in total

Review 1.  Function and pathophysiological importance of ABCB4 (MDR3 P-glycoprotein).

Authors:  Ronald P J Oude Elferink; Coen C Paulusma
Journal:  Pflugers Arch       Date:  2006-04-19       Impact factor: 3.657

Review 2.  Intrahepatic cholestasis of pregnancy.

Authors:  Victoria Geenes; Catherine Williamson
Journal:  World J Gastroenterol       Date:  2009-05-07       Impact factor: 5.742

3.  Clinical utility gene card for: progressive familial intrahepatic cholestasis type 3.

Authors:  Emmanuel Gonzales; Anne Spraul; Emmanuel Jacquemin
Journal:  Eur J Hum Genet       Date:  2013-09-04       Impact factor: 4.246

4.  Intrahepatic cholestasis of pregnancy: the severe form is associated with common variants of the hepatobiliary phospholipid transporter ABCB4 gene.

Authors:  H E Wasmuth; A Glantz; H Keppeler; E Simon; C Bartz; W Rath; L-A Mattsson; H-U Marschall; F Lammert
Journal:  Gut       Date:  2006-08-04       Impact factor: 23.059

5.  First description of ABCB4 gene deletions in familial low phospholipid-associated cholelithiasis and oral contraceptives-induced cholestasis.

Authors:  Eric Pasmant; Philippe Goussard; Laetitia Baranes; Ingrid Laurendeau; Samuel Quentin; Philippe Ponsot; Yann Consigny; Olivier Farges; Bertrand Condat; Dominique Vidaud; Michel Vidaud; Jian-Min Chen; Béatrice Parfait
Journal:  Eur J Hum Genet       Date:  2011-10-12       Impact factor: 4.246

Review 6.  The molecular genetics of intrahepatic cholestasis of pregnancy.

Authors:  P H Dixon; C Williamson
Journal:  Obstet Med       Date:  2008-12-01

Review 7.  Progressive familial intrahepatic cholestasis.

Authors:  Anshu Srivastava
Journal:  J Clin Exp Hepatol       Date:  2013-11-23

8.  Analysis of gene mutations in children with cholestasis of undefined etiology.

Authors:  Ursula Matte; Reena Mourya; Alexander Miethke; Cong Liu; Gregory Kauffmann; Katie Moyer; Kejian Zhang; Jorge A Bezerra
Journal:  J Pediatr Gastroenterol Nutr       Date:  2010-10       Impact factor: 2.839

9.  ABCB4 mutations in adult patients with cholestatic liver disease: impact and phenotypic expression.

Authors:  Dario Degiorgio; Andrea Crosignani; Carla Colombo; Domenico Bordo; Massimo Zuin; Emanuela Vassallo; Marie-Louise Syrén; Domenico A Coviello; Pier Maria Battezzati
Journal:  J Gastroenterol       Date:  2015-09-01       Impact factor: 7.527

Review 10.  Primary biliary cirrhosis.

Authors:  Simon Hohenester; Ronald P J Oude-Elferink; Ulrich Beuers
Journal:  Semin Immunopathol       Date:  2009-07-15       Impact factor: 9.623

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.